Coronavirus Essential podcast | COVAXIN trial begins in AIIMS Delhi; 65% rapid antigen test results were false negatives, claims BMC

Tune in to the Coronavirus Essential podcast with Sakshi Batra for news on the COVID-19 pandemic.

Moneycontrol News

July 24, 2020 / 19:29 IST

The human trials for COVAXIN, India's first COVID-19 vaccine developed by Bharat Biotech, began at the Delhi AIIMS hospital on Friday.

Meanwhile, reports from Mumbai claimed that two civic laboratories have noted the high incidence of false negatives in rapid antigen tests.

Tune in to the Coronavirus Essential podcast with Sakshi Batra for more news on the COVID-19 pandemic.

Moneycontrol News

first published: Jul 24, 2020 07:29 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347